These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34470483)

  • 21. Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke.
    Amarenco P; Kim JS; Labreuche J; Charles H; Giroud M; Lee BC; Mahagne MH; Nighoghossian N; Gabriel Steg P; Vicaut É; Bruckert E;
    Stroke; 2020 Apr; 51(4):1231-1239. PubMed ID: 32078484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy.
    Zhao W; Zheng XL; Jiang ZN; Liao XB; Zhao SP
    Int J Cardiol; 2017 Dec; 248():355-360. PubMed ID: 28689987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study.
    Yeh PS; Yang CM; Lin SH; Wang WM; Chen PS; Chao TH; Lin HJ; Lin KC; Chang CY; Cheng TJ; Li YH
    Atherosclerosis; 2013 Jun; 228(2):472-7. PubMed ID: 23618097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
    Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
    Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients.
    Li J; Pan Y; Xu J; Li S; Wang M; Quan K; Meng X; Li H; Lin J; Wang Y; Zhao X; Liu L; Wang Y;
    Stroke; 2021 Aug; 52(9):2827-2836. PubMed ID: 34281380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.
    Teo KK; Goldstein LB; Chaitman BR; Grant S; Weintraub WS; Anderson DC; Sila CA; Cruz-Flores S; Padley RJ; Kostuk WJ; Boden WE;
    Stroke; 2013 Oct; 44(10):2688-93. PubMed ID: 23881958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
    Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.
    Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D
    Stroke; 2021 Jan; 52(2):424-433. PubMed ID: 33493055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke.
    Higuchi E; Toi S; Shirai Y; Hoshino T; Ishizuka K; Shimizu S; Tsutsumi Y; Kitagawa K
    Stroke; 2020 Feb; 51(2):655-658. PubMed ID: 31771457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease.
    Arenillas JF; Alvarez-Sabín J; Molina CA; Chacón P; Montaner J; Rovira A; Ibarra B; Quintana M
    Stroke; 2003 Oct; 34(10):2463-8. PubMed ID: 14500938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population.
    Zhou L; Mai J; Li Y; Guo M; Wu Y; Gao X; Wu Y; Liu X; Zhao L
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1706-1713. PubMed ID: 32811737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis.
    Giugliano RP; Pedersen TR; Saver JL; Sever PS; Keech AC; Bohula EA; Murphy SA; Wasserman SM; Honarpour N; Wang H; Lira Pineda A; Sabatine MS;
    Stroke; 2020 May; 51(5):1546-1554. PubMed ID: 32312223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodontal Disease Associated with Aortic Arch Atheroma in Patients with Stroke or Transient Ischemic Attack.
    Sen S; Chung M; Duda V; Giamberardino L; Hinderliter A; Offenbacher S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2137-2144. PubMed ID: 28551291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke.
    Okuzumi A; Ueno Y; Shimada Y; Tanaka Y; Miyamoto N; Yamashiro K; Tanaka R; Hattori N; Urabe T
    J Neurol Sci; 2013 Mar; 326(1-2):83-8. PubMed ID: 23414726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between dyslipidemia and carotid plaques in a high-stroke-risk population in Shandong Province, China.
    Mi T; Sun S; Zhang G; Carora Y; Du Y; Guo S; Cao M; Zhu Q; Wang Y; Sun Q; Wang X; Qu C
    Brain Behav; 2016 Jun; 6(6):e00473. PubMed ID: 27134771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Related cardiometabolic factors and prevalence of low HDL-cholesterol levels and atherogenic dyslipidemia. SIMETAP-AD study.
    Ruiz-García A; Arranz-Martínez E; García-Fernández ME; Cabrera-Vélez R; García-Pliego RA; Morales-Cobos LE; Sanz-Pozo B; Gómez-Díaz E; Rodríguez-de-Mingo E; Rico-Pérez MR; Migueláñez-Valero A; Calderín-Morales MP; Sandín-de-Vega E; Hombrados-Gonzalo MP; Luna-Ramírez S; Sánchez-Ramos MC; Mora-Casado C; Moreno-Muñoz MS; González-Escobar P; Ruiz-Díaz L; Caballero-Ramírez N; Zamora-Gómez MM; Iturmendi-Martínez N; Holgado-Catalán MS; Álvarez-Benedicto R; Sanchidriá-Fernández PL; Benito-Alonso E; Fernández-Vicente T; Hernández-López RM; Doria-Carlin NA; Frías-Vargas MJ;
    Clin Investig Arterioscler; 2021; 33(1):19-29. PubMed ID: 33082056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherogenic dyslipidemia in patients with established coronary artery disease.
    Lahoz C; Mostaza JM; Tranche S; Martin-Jadraque R; Mantilla MT; López-Rodriguez I; Monteiro B; Sanchez-Zamorano MA; Taboada M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):103-8. PubMed ID: 20675108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study.
    Tanne D; Koren-Morag N; Goldbourt U
    Stroke; 2004 Oct; 35(10):2351-5. PubMed ID: 15308782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.